kaonavi
4435
D. Western Therapeutics Institute
4576
Itamiarts
168A
Nakayo
6715
Allied Telesis Holdings KK
6835
(Q3)Dec 31, 2024 | (Q2)Sep 30, 2024 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||||
Cash from operating activities | -13.73%4.17B | -38.17%2.29B | -40.46%1.09B | 71.95%15.83B | 22.33%5.47B | 78.29%4.84B | 166.35%3.7B | 187.58%1.83B | 22.45%9.21B | 117.68%4.47B |
Net profit before non-cash adjustment | -11.81%2.91B | -10.28%1.9B | 10.67%1.64B | 149.82%8.8B | 127.39%1.9B | 241.35%3.29B | 171.10%2.12B | 57.89%1.48B | -15.14%3.52B | 846.43%836M |
Total adjustment of non-cash items | 80.98%2.44B | -45.77%1.22B | -48.13%956M | -2.68%7.45B | 9.52%2.01B | -41.66%1.35B | 37.62%2.25B | -1.76%1.84B | 11.17%7.65B | -18.41%1.84B |
-Depreciation and amortization | 1.00%1.93B | 7.14%1.98B | 7.14%1.92B | 6.94%7.63B | 13.83%2.08B | 5.07%1.91B | 3.64%1.85B | 4.98%1.79B | 4.46%7.14B | 2.93%1.83B |
-Reversal of impairment losses recognized in profit and loss | ---- | ---- | ---- | -27.83%83M | 4,050.00%83M | ---- | ---- | ---- | -77.97%115M | -99.62%2M |
-Share of associates | --0 | 200.00%8M | -18.18%-13M | 5.13%-37M | 38.46%-8M | -100.00%-10M | 52.94%-8M | -175.00%-11M | -290.00%-39M | -225.00%-13M |
-Disposal profit | -33.33%2M | -20.00%8M | -66.67%2M | 9.68%102M | 250.91%83M | -57.14%3M | --10M | -95.74%6M | -40.38%93M | -212.24%-55M |
-Net exchange gains and losses | 87.50%-1M | -382.35%-48M | -72.09%12M | 1,950.00%82M | 3.45%30M | ---8M | -52.78%17M | 170.49%43M | -93.85%4M | -36.96%29M |
-Other non-cash items | 192.87%508M | -294.16%-732M | -7,523.08%-965M | -220.06%-413M | -644.68%-256M | -213.02%-547M | 234.64%377M | -86.02%13M | 150.59%344M | 134.56%47M |
Changes in working capital | -696.43%-1.17B | -24.18%-832M | -0.80%-1.51B | 78.72%-419M | -13.56%1.55B | 135.19%196M | 34.70%-670M | 31.40%-1.49B | 44.03%-1.97B | 2,091.11%1.79B |
-Change in receivables | -639.66%-3B | 132.16%986M | -18.65%-948M | -24.84%-1.4B | -35.43%2.87B | 88.64%-406M | -668.42%-3.07B | 49.94%-799M | 30.93%-1.12B | 80.20%4.45B |
-Change in inventory | -1,957.58%-679M | -90.55%52M | -103.23%-126M | 74.67%-135M | -220.90%-590M | -32.00%-33M | 127.27%550M | 94.99%-62M | 79.81%-533M | 3,150.00%488M |
-Change in payables | 295.28%2.51B | -200.38%-1.87B | 32.18%-432M | 440.74%828M | 66.30%-1.03B | -79.16%635M | 316.14%1.86B | -201.11%-637M | -126.76%-243M | -28.15%-3.06B |
-Provision for loans, leases and other losses | --3M | 86.67%-2M | --0 | 485.14%285M | 436.36%296M | --0 | -87.50%-15M | -84.62%4M | 55.42%-74M | 43.95%-88M |
Dividends paid (cash flow from operating activities) | ||||||||||
Dividends received (cash flow from operating activities) | ||||||||||
Interest paid (cash flow from operating activities) | -20.00%-48M | -23.26%-53M | -18.60%-51M | -20.14%-167M | 2.38%-41M | 2.44%-40M | -34.38%-43M | -79.17%-43M | -23.01%-139M | -40.00%-42M |
Interest received (cash flow from operating activities) | -25.35%106M | 42.37%168M | 62.00%162M | 52.75%527M | -4.57%167M | 140.68%142M | 110.71%118M | 81.82%100M | 104.14%345M | 272.34%175M |
Tax refund paid | -200.00%-927M | -40.54%-208M | -63.28%-498M | -31.05%-1.38B | -146.22%-618M | 20.77%-309M | 49.66%-148M | -158.47%-305M | 37.73%-1.05B | -310.92%-251M |
Other operating cash inflow (outflow) | -103.33%-2M | 1,100.00%10M | -1M | 133.61%855M | 334.97%796M | -18.92%60M | -100.91%-1M | 0 | 311.24%366M | 105.62%183M |
Operating cash flow | -29.59%3.3B | -39.19%2.2B | -55.66%701M | 79.54%15.67B | 27.28%5.77B | 94.20%4.69B | 195.03%3.62B | 188.50%1.58B | 46.10%8.73B | 99.03%4.53B |
Investing cash flow | ||||||||||
Net business purchase and sale | ---- | ---- | ---- | ---551M | ---7M | ---- | ---- | ---- | --0 | --0 |
Net investment product transactions | 18,700.00%372M | -2,550.00%-53M | -16,200.00%-326M | -103.78%-7M | -100.39%-1M | -113.33%-2M | 60.00%-2M | 97.62%-2M | 272.90%185M | 26,000.00%259M |
Net changes in other investments | -50.56%-2.16B | 0.41%-2.18B | -70.50%-2.06B | -12.53%-7.5B | -58.53%-2.67B | 23.97%-1.43B | -14.27%-2.19B | -2.46%-1.21B | -15.26%-6.66B | 23.71%-1.68B |
Investing cash flow | -8.94%-2.16B | -1.92%-2.23B | -97.11%-2.39B | -24.36%-8.06B | -87.92%-2.68B | -5.83%-1.98B | -14.08%-2.19B | 4.19%-1.21B | -10.02%-6.48B | 35.48%-1.42B |
Financing cash flow | ||||||||||
Net issuance payments of debt | -78.71%773M | -32.36%602M | 81.62%-603M | -110.31%-319M | -621.40%-1.56B | 1,376.02%3.63B | -53.65%890M | -622.45%-3.28B | 589.40%3.09B | 221.05%299M |
Net common stock issuance | --0 | --0 | --0 | ---6.06B | ---20M | ---6.04B | --0 | --0 | --0 | --0 |
Increase or decrease of lease financing | -17.65%-120M | -19.57%-110M | -26.60%-119M | 2.23%-394M | -6.00%-106M | 8.11%-102M | 7.07%-92M | -1.08%-94M | -62.50%-403M | ---100M |
Cash dividends paid | -40.67%-1.05B | --0 | -40.67%-1.05B | 0.00%-1.49B | --0 | 0.00%-745M | --0 | 0.00%-745M | 0.00%-1.49B | --0 |
Cash dividends for minorities | -900.00%-10M | --0 | -14.84%-209M | -0.55%-183M | --0 | ---1M | --0 | 7.61%-182M | 4.71%-182M | --15M |
Net other fund-raising expenses | ---2M | --0 | 50.00%-1M | 0.00%-2M | ---- | ---- | --0 | ---2M | 50.00%-2M | --0 |
Financing cash flow | 87.50%-407M | -38.35%492M | 54.00%-1.98B | -931.59%-8.45B | -888.32%-1.69B | -433.77%-3.26B | -56.13%798M | -957.49%-4.3B | 139.61%1.02B | 169.03%214M |
Net cash flow | ||||||||||
Beginning cash position | -12.70%12.38B | 5.55%11.64B | -0.29%14.65B | 39.70%14.7B | 15.32%13.86B | 19.66%14.18B | 10.55%11.03B | 39.70%14.7B | -14.32%10.52B | 14.39%12.01B |
Current changes in cash | 235.16%738M | -79.18%465M | 6.79%-3.67B | -125.74%-840M | -57.64%1.41B | -727.27%-546M | 97.79%2.23B | -250.09%-3.94B | 231.52%3.26B | 1,490.79%3.32B |
Effect of exchange rate changes | -647.56%-1.23B | -70.34%272M | 147.35%653M | -12.71%797M | 4.99%-609M | -4.26%225M | 23.58%917M | -54.25%264M | 26.28%913M | -351.37%-641M |
Cash adjustments other than cash changes | ---- | ---- | ---1M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
End cash Position | -14.25%11.88B | -12.70%12.38B | 5.55%11.64B | -0.29%14.65B | -0.29%14.65B | 15.32%13.86B | 19.66%14.18B | 10.55%11.03B | 39.70%14.7B | 39.70%14.7B |
Free cash flow | -29.59%3.3B | -39.19%2.2B | -55.66%701M | 79.54%15.67B | 27.28%5.77B | 94.20%4.69B | 195.03%3.62B | 188.50%1.58B | 46.10%8.73B | 99.03%4.53B |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |